I agree that this site is using cookies. You can find further informations here.
X
Staropoli, Nicoletta
74  results:
Search for persons X
?
1

The impact of PARP inhibitors in the whole scenario of ovar..:

Staropoli, Nicoletta ; Ciliberto, Domenico ; Luciano, Francesco...
Critical Reviews in Oncology/Hematology.  193 (2024)  - p. 104229 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Why do you treat pCR patient with pertuzumab and trastuzuma..:

Sanò, Maria Vita ; Staropoli, Nicoletta
Clinical Breast Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

LNA-i-miR-221 activity in colorectal cancer: A reverse tran..:

Ali, Asad ; Grillone, Katia ; Ascrizzi, Serena...
Molecular Therapy - Nucleic Acids.  35 (2024)  2 - p. 102221 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Genetic Biomarkers of Sorafenib Response in Patients with H..:

Giannitrapani, Lydia ; Di Gaudio, Francesca ; Cervello, Melchiorre...
International Journal of Molecular Sciences.  25 (2024)  4 - p. 2197 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Gut Microbiota Are a Novel Source of Biomarkers for Immunot..:

Del Giudice, Teresa ; Staropoli, Nicoletta ; Tassone, Pierfrancesco..
Cancers.  16 (2024)  10 - p. 1806 , 2024
Link: https://doi.org/10.3390/..
 
?
6

Identification of ADME genes polymorphic variants linked to..:

Staropoli, Nicoletta ; Scionti, Francesca ; Farenza, Valentina...
Biomedicine & Pharmacotherapy.  174 (2024)  - p. 116478 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Sacituzumab Govitecan for the treatment of advanced triple ..:

Caputo, Roberta ; Buono, Giuseppe ; Piezzo, Michela...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
8

Safety and activity of the first-in-class locked nucleic ac..:

Tassone, Pierfrancesco ; Di Martino, Maria Teresa ; Arbitrio, Mariamena...
Journal of Hematology & Oncology.  16 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
9

The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecifi..:

Polerà, Nicoletta ; Mancuso, Antonia ; Riillo, Caterina...
Cancers.  15 (2023)  6 - p. 1647 , 2023
Link: https://doi.org/10.3390/..
 
?
10

Risk-Based Therapeutic Strategies for HER2-Positive Early B..:

Garutti, Mattia ; Cucciniello, Linda ; Arpino, Grazia...
Clinical Breast Cancer.  23 (2023)  7 - p. e458-e469 , 2023
Link: https://doi.org/10.1016/..
 
?
11

First-line systemic treatment for hepatocellular carcinoma:..:

Ciliberto, Domenico ; Caridà, Giulio ; Staropoli, Nicoletta...
Heliyon.  9 (2023)  8 - p. e18696 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Prevalence of Non-erosive Esophageal Phenotypes in Children..:

Blasi, Elisa ; Stefanelli, Ettore ; Tambucci, Renato...
Journal of Neurogastroenterology and Motility.  29 (2023)  2 - p. 156-165 , 2023
Link: https://doi.org/10.5056/..
 
?
13

UMG1/CD3ε‐bispecific T‐cell engager redirects T‐cell cytoto..:

Caracciolo, Daniele ; Polerà, Nicoletta ; Belmonte, Beatrice...
British Journal of Haematology.  204 (2023)  2 - p. 555-560 , 2023
Link: https://doi.org/10.1111/..
 
?
14

Pembrolizumab plus lenvatinib in advanced endometrial cance..:

Staropoli, Nicoletta ; Salvino, Angela ; Falcone, Federica...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
15

Genetic biomarkers for sorafenib response in patients with ..:

Augello, Giuseppa ; Arbitrio, Mariamena ; Giannitrapani, Lydia...
Journal of Hepatology.  78 (2023)  - p. S568 , 2023
Link: https://doi.org/10.1016/..
 
1-15